AngioDynamics, Inc.
ANGO
$13.59
$0.151.12%
NASDAQ
| 05/31/2026 | 02/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 10.44% | -1.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.44% | -1.27% | |||
| Cost of Revenue | 7.82% | 6.62% | |||
| Gross Profit | 12.76% | -7.38% | |||
| SG&A Expenses | 8.42% | 3.54% | |||
| Depreciation & Amortization | 1.87% | 0.95% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.73% | 3.58% | |||
| Operating Income | 12.12% | -158.19% | |||
| Income Before Tax | -36.71% | -27.02% | |||
| Income Tax Expenses | 2,983.33% | 340.00% | |||
| Earnings from Continuing Operations | -41.08% | -27.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -41.08% | -27.31% | |||
| EBIT | 12.12% | -158.19% | |||
| EBITDA | 57.88% | -125.73% | |||
| EPS Basic | -40.76% | -27.08% | |||
| Normalized Basic EPS | -317.60% | 43.03% | |||
| EPS Diluted | -40.76% | -27.08% | |||
| Normalized Diluted EPS | -317.60% | 43.03% | |||
| Average Basic Shares Outstanding | 0.24% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.24% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||